Pilot Study on Breathing Exercises and Pulmonary Function in Children With Cerebral Palsy: A Randomized Trial

February 20, 2025 updated by: Semmelweis University

Pilot Study on the Effects of Conductive Breathing Exercises on Pulmonary Function in School-Aged Children With Cerebral Palsy: A Randomized Controlled Trial

This pilot study is a randomized controlled trial aimed at investigating the efficacy of protocolized conductive breathing exercises combined with regular air ventilation, in addition to standard care, on various aspects of health in school-aged children with cerebral palsy (CP). The primary objectives of the study include assessing the effects on pulmonary functions, quality of life (QoL), depression anxiety and stress (DAS) levels, eating-drinking ability (EDACS), and severity of drooling in this population.

The study compares two groups of participants: one group undergoes protocolized conductive breathing exercises three times per day for five minutes, five days a week, while the other group receives only standard rehabilitation care. Evaluations include spirometry parameters ( forced vital capacity [FVC] forced expiratory volume in the first second [FEV1], FEV1/FVC ratio and peak expiratory flow [PEF]. Assessments are conducted at the beginning and end of the eight weeks intervention period, with additional evaluations after a 2.5-month washout period.

The conductive breathing exercises, developed by Dr. András Pető, the founder of the conductive education system, consist of techniques such as diaphragmatic breathing, deep breathing, and playful forced expiration.

Respiratory well-being is crucial, particularly in pediatric CP patients, as compromised pulmonary functions can significantly impact overall health. Despite this, there is currently a lack of established protocols and research regarding the efficacy of conductive breathing exercises in this specific population. Therefore, the this study seeks to address this gap by determining whether a structured regimen of conductive breathing exercises, when added to standard care, can lead to measurable improvements in respiratory health and QoL among school-aged children with CP.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pest
      • Budapest, Pest, Hungary, 1125
        • Semmelweis University, Conductive Pedagogical Methodology Institution and College.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Eligibility Criteria:

Inclusion Criteria:

  • Children with cerebral palsy (GMFCS I-V)
  • School-Aged 12-22 years, of both genders
  • Teens and adolescents attending continuous standard care
  • Capable of understanding and following commands given by the therapist
  • Children who do not require respiratory support

Exclusion Criteria:

  • Children who have received recent surgical procedures or botulinum toxin injections
  • Children who are unable to perform spirometry

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Arm
In this group, participants received conductive education as standard rehabilitation care plus the procolized breathing exercesis. In this group, participants followed a strict protocol for breathing exercises over an 8-week period, performing them three times a day, Monday through Friday, for five minutes each session. They also adhered to prescribed ventilation guidelines, in addition to receiving standard rehabilitation care.
During the intervention, participants perform respiratory exercises, including deep breathing, belly breathing, exhalation with vocalization, and forced exhalation. Each exercise is repeated five times, three times per day: twice in the morning and once in the afternoon. The exercises are conducted in a seated, corrected position, guided by rehabilitation specialists or special needs teachers who provide instructions and demonstrations. Teachers are provided with the exact protocol for the breathing exercises series. Each breathing exercise focuses on maintaining a specific rhythm, with inhalation lasting approximately 3-4 seconds, holding for 1-2 seconds, and exhalation for 5-6 seconds. Forced exhalation is facilitated using playful motivational tools such as windmills and balloon blowing. The protocol includes instructions for the breathing exercises in first-person singular. The entire session lasts approximately 5 minutes, resulting in a total of 15 minutes of training per day.
No Intervention: Control Arm
In this group, participants received conductive education as standard rehabilitation care plus sham breathing exercises. Participants in this group followed a strict 8-week protocol for breathing exercises, which included a sham breathing protocol, performing the exercises three times a day, Monday through Friday, for one minutes each session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Forced Expiratory Volume in 1st second (FEV1) in (L)
Time Frame: • Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks

Change from baseline in forced expiratory volume in 1st second (FEV1)

  • Description: FEV1 is the maximal volume of air that can be expired in the first second of forced vital capacity maneuver using spirometry.
  • Units of Measure: L (Liter)
• Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks
Forced Expiratory Volume in 1st second (FEV1) in %
Time Frame: Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks

Change from baseline in forced expiratory volume in 1st second (FEV1)

• Units of Measure: Percentage (%) The mentioned outcome will be measured using a spirometer and calculated according to the Quanjer, 1993 (ECCS) standards.

Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks
Forced Vital Capacity (FVC) in (L)
Time Frame: Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks
  • Description: FVC is the maximal volume of air that can be forcefully exhaled after taking the deepest breath possible, measured using spirometry.
  • Units of Measure: L (Liter)
Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks
Forced Vital Capacity (FVC) in %
Time Frame: Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks

FVC is the maximal volume of air that can be forcefully exhaled after taking the deepest breath possible, measured using spirometry.

• Units of Measure: Percentage (%)

The mentioned outcome will be measured using a spirometer and calculated according to the Quanjer, 1993 (ECCS) standards:

Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks
FEV1/FVC Ratio
Time Frame: Measured at 0, 8, and 18 weeks.

Description: This is already a combined measurement (a ratio of Forced Expiratory Volume in the first second to Forced Vital Capacity).

No unit.

Measured at 0, 8, and 18 weeks.
Peak Expiratory Flow (PEF) in (L/sec)
Time Frame: Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks

Description: Peak Expiratory Flow (PEF) is the highest speed at which air can be forcefully exhaled from the lungs after taking the deepest breath possible, measured using spirometry.

Units of Measure: L/sec (Liter/secundum)

Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks
Peak Expiratory Flow (PEF) in %
Time Frame: Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks
Description: Peak Expiratory Flow (PEF) is the highest speed at which air can be forcefully exhaled from the lungs after taking the deepest breath possible, measured using spirometry. • Units of Measure: Percentage (%) The mentioned outcome will be measured using a spirometer and calculated according to the Quanjer, 1993 (ECCS) standards.
Time Frame: Measurement at 0 weeks, 8 weeks, and 18 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cerebral Palsy Quality of Life
Time Frame: measurement at 0 weeks, 8 weeks, 18 weeks

The CP QoL test measures changes in quality of life (QoL) across different domains, such as social and emotional well-being, acceptance, bodily pain, and functioning. The assessment is conducted at three time points: 0 weeks, 8 weeks, and 18 weeks.

Scoring and Interpretation:

Scale: Scores are recorded from 1 to 9, where 1 = Very unhappy and 9 = Very happy. Higher scores indicate better quality of life (QoL).

measurement at 0 weeks, 8 weeks, 18 weeks
Severity and Frequency of Drooling
Time Frame: measurement at 0 weeks, 8 weeks, 18 weeks
The severity and frequency of drooling will be assessed for changes.
measurement at 0 weeks, 8 weeks, 18 weeks
Depression level
Time Frame: measurement at 0 weeks, 8 weeks, 18 weeks

Depression Scale (DAS-D): Measures symptoms of depression such as low mood, hopelessness, and loss of interest.

• Scale Details:

  • Minimum Score: [0]
  • Maximum Score: [28]

In this scale, higher scores represent worse outcomes (indicating more severe depression symptoms), while lower scores reflect better mental health (indicating fewer or less severe symptoms of depression).

measurement at 0 weeks, 8 weeks, 18 weeks
Anxiety level
Time Frame: measurement at 0 weeks, 8 weeks, 18 weeks

Anxiety Scale (DAS-A): Assesses symptoms related to anxiety, including nervousness, panic, and fear.

Scale Details:

  • Minimum Score: [0]
  • Maximum Score: [20] In this scale, higher scores represent worse outcomes (indicating more severe anxiety symptoms), while lower scores reflect better mental health (indicating fewer or less severe symptoms of anxiety).
measurement at 0 weeks, 8 weeks, 18 weeks
Stress level
Time Frame: measurement at 0 weeks, 8 weeks, 18 weeks

Stress Scale (DAS-S): Evaluates stress-related symptoms like irritability, tension, and difficulty relaxing.

Scale Details:

  • Minimum Score: [0]
  • Maximum Score: [34] In this scale, higher scores represent worse outcomes (indicating more severe stress symptoms), while lower scores reflect better mental health (indicating fewer or less severe symptoms of stress).
measurement at 0 weeks, 8 weeks, 18 weeks
Eating Ability
Time Frame: measurement at 0 weeks, 8 weeks, 18 weeks
Measured with EDACS test, changes in Eating and Drinking Ability, encompassing oral-motor skills, pharyngeal function, eating skills, and drinking skills. It assesses the coordination of mouth, tongue, and jaw movements, swallowing function, food preparation, grasping, and consumption of both food and liquids.
measurement at 0 weeks, 8 weeks, 18 weeks
Drinking Ability
Time Frame: measurement at 0 weeks, 8 weeks, 18 weeks
Measured with EDACS test, changes in Eating and Drinking Ability, encompassing oral-motor skills, pharyngeal function, eating skills, and drinking skills. It assesses the coordination of mouth, tongue, and jaw movements, swallowing function, food preparation, grasping, and consumption of both food and liquids.
measurement at 0 weeks, 8 weeks, 18 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2024

Primary Completion (Estimated)

February 28, 2025

Study Completion (Estimated)

March 30, 2025

Study Registration Dates

First Submitted

January 29, 2025

First Submitted That Met QC Criteria

February 20, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 20, 2025

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Series of breathing exercises

Subscribe